Carboni, … DiChiara et al. J Neurosci 20:RC102(1-5), 2000 What do we know about addictive drugs from animal studies? “… cocaine, morphine, nicotine, and.

Slides:



Advertisements
Similar presentations
Acute Effects of Cocaine on Human Brain Activity & Emotion John W. Candler Biology Department Eastern Connecticut State University.
Advertisements

Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes of Health Overlapping Neuronal Circuits In.
Wanting Things How Your Brain Works - Week 8 Dr. Jan Schnupp HowYourBrainWorks.net.
Addiction: Wise: Drug dependence-- cluster of cognitive, behavioral
Tobacco Lesson 1. Tobacco has ____________ effects on almost all body systems. cigarette lungs cancer tobacco harmful crave oxygen.
PSYA4 Addictive Behaviour
1 Decision making. 2 How does the brain learn the values?
N = 6 males. no trick subjects apprised of drink type just before scan is this different from Urban? Is it different from Yoder?
Imaging Drugs in the Brain ENAS 880 / NSCI 523 Fall 2010 Morris/Cosgrove kelly
Methods 10 regular smokers with Fagerstrom Test for Nicotine Dependence (FTND = 3.4) were randomised to start with either an exercise (10 minutes stationary.
Anxiety and Depression in Chemical Dependency Recovery Groups Erin Brock Hanover College.
Carboni, … DiChiara et al. J Neurosci 20:RC102(1-5), 2000 What do we know about addictive drugs from animal studies? “… cocaine, morphine, nicotine, and.
Participants: 21 smokers (13M, ages 18-45) and 21 age-, gender-, race-, and education-matched controls. Procedure: Stimuli were 100 photographs: 50 food.
Imaging Drugs in the Brain ENAS 880 / NSCI 523 Fall 2010 Morris/Cosgrove kelly
ADDICTION Smoking: Biochemistry. Initiation  Nicotine nucleus accumbens  Brain reward centre  Increases dopamine in mesolimbic pathway  Ventral Tegmental.
Examination of Age-Related Cholinergic Activity during Nicotine Exposure and Withdrawal Luis M Carcoba, M.D, Ph.D. University of Texas at El Paso Department.
Director, National Institute on Drug Abuse National Institute Alcohol
Models of addiction: role of dopamine and other neurobiological substrates Paul E. M. Phillips, Ph.D. Department of Psychiatry and Behavioral Sciences.
This is your Brain: Teaching About Neuroscience and Addiction Research
Drug Tolerance Cross Tolerance Metabolic Tolerance
Synaptic plasticity Basic Neuroscience NBL 120. classical conditioning CS (neutral) - no response US - UR After pairing: CS - CR.
Drugs & Consciousness. Drugs & the Brain Blood brain barrier – layer of capillaries that protect the brain Blood brain barrier – layer of capillaries.
Dr Jonathon Arnold Room 211 c Bosch Building Department of Pharmacology
Substance Use and Abuse Smoking. Smoking Tobacco: Who Smokes? Varies with age Gender differences Educational differences.
Intimate Partner Violence & Methamphetamine Claudia J. Wilcox, CADC II Policy & Program Development Specialists April 27, 2007.
Copyright © 2009 Allyn & Bacon Chemicals That Harm with Pleasure This multimedia product and its contents are protected under copyright law. The following.
The Biological Approach to Addiction The Brain! Understand the Assumptions of the Biological Approach Evaluate the Biological Approach Answer the exam.
Neurological Disorders Lesson 5.2 How do drugs alter synaptic transmission? Human Brain Rat Brain.
 What is drugs?  WHAT IS DRUG ADDICTION?  A drug is any chemical you take that affects the way your body works. Alcohol, caffeine, aspirin and nicotine.
Psychoactive Drug States  Human drug use has occurred for millenia  Psychoactive drugs: chemicals that affect mental processes and behavior by their.
Addiction and the Brain
Addiction. Addiction is a state characterized by compulsive engagement in rewarding stimuli despite adverse consequences.
A dual role for nicotine in reinforcement: the interaction between nicotine and non-drug cues (What can a lab rat tell us about why people smoke?) Nadia.
Glencoe Making Life Choices Section 1 Why People Use Tobacco Chapter 14 Tobacco 1 > HOME Chapter Tobacco 14  Section 1 Why People Use Tobacco.
The Neurobiology of Free Will In National Institute on Drug Abuse
Common Brain Mechanisms in ADDICTION Common Brain Mechanisms in ADDICTION Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow,
1 Drugs and Consciousness Module States of Consciousness Overview Drugs and Consciousness  Dependence and Addiction  Psychoactive Drugs  Influences.
Central Nervous System Stimulants Constricted Blood Vessels Constricted Blood Vessels Increased Pulse Increased Pulse Increased Blood Pressure Increased.
Advances in science have revolutionized our fundamental views of drug abuse and addiction. Science has come a long way in helping us understand how drugs.
Risk factors in the Development of addiction. Why are some people more venerable to addiction than others?
Unit 3: Health psychology – substance misuse The use of humans in drug research.
NATIONAL INSTITUTE ON DRUG ABUSE NIDA NIAAA National Institute Alcohol Abuse and Alcoholism Nora D. Volkow, M.D. Director, National Institute on Drug Abuse.
11 Motivation  Nicotine causes DA release in the striatum, part of the mesolimbic DA pathway which mediates reinforcing behaviors (Martin-Soelch et al,
Neural correlates of risk sensitivity An fMRI study of instrumental choice behavior Yael Niv, Jeffrey A. Edlund, Peter Dayan, and John O’Doherty Cohen.
Jon-Kar Zubieta, M.D., Ph.D. Phil F. Jenkins Professor of Psychiatry Professor Departments of Psychiatry, Radiology, and Neurosciences Program Research.
Varenicline: A Tale of Three Molecules Douglas E. Jorenby, Ph.D. Associate Professor of Medicine Univ. of WI School of Medicine and Public Health The Center.
DRUGS IN SPORT. Learning Objectives You will learn the difference between socially acceptable and socially unacceptable drugs. You will learn about drugs.
NICOTINE and the BRAIN Wilson M. Compton, MD, MPE Deputy Director, U.S. National Institute on Drug Abuse.
Drugs and Consciousness
Addiction I’ve never met a person who said they wish they had tried drugs and alcohol sooner…
Alcohol and nicotine interactions: behavioural studies
Adolescents and Substance Abuse
Drugs Tolerance Dependence Addiction Psychoactive drugs Terotagens
Neuroimaging of associative learning
Motivation Not all responses can be explained by
Drug Effects Why take drugs? How do drugs influence synapses?
AP Psych: Types of Drugs
motivation, reward & addiction
Chapter 3 (F): Drugs and Consciousness
Average for the DV ratio (DVR) images for [11C]raclopride for the controls (n = 20) and the alcoholics (n = 20) at the level of striatum after placebo.
Regression slopes between percentage changes in Bmax′/Kd′ (dependent variable) in VS and absolute regional brain metabolic activity in OFC (BA 11), anterior.
Drugs.
Neuroimaging of associative learning
Chapter 5 (C): Drugs and Consciousness
The Brain on Drugs: From Reward to Addiction
Neuroimaging of associative learning
States of consciousness
The dopamine (DA) response to cocaine infusion in the NAc in constitutive p11 KO mice is restored by nicotinic or muscarinic receptor stimulation in the.
Presentation transcript:

Carboni, … DiChiara et al. J Neurosci 20:RC102(1-5), 2000 What do we know about addictive drugs from animal studies? “… cocaine, morphine, nicotine, and ethanol share the property of increasing DA transmission in the BNST. This effect may be related to an action at the level of neuronal circuits activated by natural reinforcers … suggest[ing] that DA transmission of the BNST plays a role in the mechanism of drug abuse and addiction.”

aaarrrggghhhh!!!!! – show me  BP

what phenomenon is this?

does everyone understand what they are showing here? euphoria  BP Individual subjects (need to have all brains in same space) plot R value at given voxel

de-nic cignic cig

muD2

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects10 smokers 20 smokers (control, smoking) 6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects10 smokers 20 smokers (control, smoking) 6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects10 smokers 20 smokers (control, smoking) 6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects10 smokers 20 smokers (control, smoking) 6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects10 smokers 20 smokers (control, smoking) 6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects10 smokers 20 smokers (control, smoking) 6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects10 smokers 20 smokers (control, smoking) 6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects10 smokers 20 smokers (control, smoking) 6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects 20 smokers (10 smoking 10 control) 10 smokers6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects 20 smokers (10 smoking 10 control) 10 smokers6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects 20 smokers (10 smoking 10 control) 10 smokers6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects 20 smokers (10 smoking 10 control) 10 smokers6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects 20 smokers (10 smoking 10 control) 10 smokers6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects 20 smokers (10 smoking 10 control) 10 smokers6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typehigh/low nicown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects 20 smokers (10 smoking 10 control) 10 smokers6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typeown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects 20 smokers (10 smoking 10 control) 10 smokers6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typeown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott tracer11C-raclopride 11C-raclopride (and carfentanil) injection protocolBolus + infusionBolus (x2)bolus + infusion tracer dose?10 mCi10-15 mCi Kbol (ml/[ml/min])100 mininfinite 90? (half and half in 90 min study) scanner (resolution)ECAT 953 (5.6 mm FWHM)HR+ (4.2 mm FWHM)HR+ (5.5 mm?) designinter-subject (1 scan)intra-subject (s scan) intra-subject (1 scan – 2 different cigs) phenomenon to testsmoking nicotine (only) subjects 20 smokers (10 smoking 10 control) 10 smokers6 smokers (m) smoking characteristics>15 cigs/day>18 cigs/day16.7 time from last cig 2 hrs (in w/d from caffeine, alcohol)) 12 hrsovernight protocol smoke 1 cigarette OUTSIDE scanner smoke 3-6 cigarettes INSIDE scanner in scanner nic--- and denic (control) cigs t=50min – 60 min smoke every 12 min -15 mn (denic) and (nic) self-adminyes forced smoking (some aversion) yes cigarette typeown brand high nic / low nic (research) finding in Ventr Str  BP corr w/ craving (reduction? all +) none yes “ventr basal ganglia” corr with dependence score finding in Dorsal Strnone?  BP related to pleasure (+,-) no

BrodyBarrettScott limitations movement low n low resolution scanner forced smoking aversion to cigs low n forced smoking? not regular brand very low n. model srtm ? don’t believe it (it was an infusion, I think they just used target/ref – 1) srtm Logan plot (use Logan slope from 5-40 and 45-90) (can’t find publication validating this approach) other calculations correlation images (understand what they did?) questions reward-prediction error? some foiund cigs aversive – DA went down – tha towuld hurt the differece reward-prediction error? got de-nic cig first, if DA went down that would help the difference order effects?yesnoyes best quote

No CS CS unexpected reward predicted reward absence of predicted reward from: Schultz, Dayan, & Montague, 1997, Science.

mu